Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

Weaver supported an aviation management firm with sell-side financial and tax assistance, saving the client over $1 million in post-close adjustments.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.
Download our white paper to learn how to even begin to measure and report GHG emissions.
J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.
The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
Explore year-end considerations including the critical aspects of 45Z credits, ITC for biogas and strategies for clean fuel production credits.
Weaver has developed carbon accounting processes to determine our carbon footprint across Scope 1 and Scope 2 emissions.
Microsoft has reformed the calculation of its supply-chain emissions through innovative accounting to align with its carbon-negative 2030 goals. Learn more here.
With an increasing demand for lithium across the energy sector, oilfields may find a common biproduct may hold the key to future growth.
The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.
As Local Law 97 mandates emission reductions for large buildings in NYC, property owners are taking proactive steps to ensure compliance and avoid fines.
On this episode of Weaver: Beyond the Numbers, Energy Evolution, our hosts discuss new information on a blender’s credit, ethanol and sustainable aviation fuel (SAF).
1 2 3 4 9